Nursing homes are designed to care for patients with physical infirmities. But nationwide, 1 in 5 residents has been diagnosed with a serious mental illness, such as schizophrenia or psychosis — ...

Eli Lilly (the company behind Mounjaro and Zepbound) just announced impressive phase 3 clinical trial results for a new weight loss medication, orforglipron, a GLP-1. Experts say that the drug has a ...